| Old Articles: <Older 61-70 Newer> |
|---|
 |
BusinessWeek
September 26, 2005 |
Israel Shakes Up Its Banking Sector The Israeli government hopes to get out of the banking business by yearend.   |
BusinessWeek
September 5, 2005
Stanley Reed |
Egypt's Minister Of Modernization When it comes to getting the state out of the economy, Foreign Trade & Industry Minister Mohamed Rachid is all business. |
The Motley Fool
August 1, 2005
Stephen D. Simpson |
Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance. |
The Motley Fool
July 7, 2005
Brian Gorman |
Let's Grab a Burger, Where? The company behind Hardee's and Carl's Jr. chains is concentrating on markets below the radar, with new restaurants opening in Russia, Jordan, Singapore and Malaysia. It's a strategy worth watching. |
BusinessWeek
July 11, 2005
Reed & Pirouz |
Election Aftershock in Corporate Iran The President-elect of Iran is anti-capitalist and anti-West, so investment may suffer. |
CIO
July 1, 2005
Stephanie Overby |
Wrist Warrior Introduced by Israel-based Tadiran Spectralink, the V-Rambo uses analog video technology to receive live images and telemetry data from sources such as surveillance aircraft and satellites. The device displays the information in real-time on the color screen on the soldier's wrist. |
Military & Aerospace Electronics
June 2005 |
Steadicopter Builds Autonomous UAV By combining a patented computer program and Global Positioning Satellite (GPS) with an existing minicopter, an Israeli company has developed an unmanned aerial vehicle (UAV) that could be the next homeland-security defense tool. |
The Motley Fool
June 14, 2005
Rich Smith |
Iran: Defender of Trademarks Iran is going out of its way to defend well-known trademarks of American companies against homegrown Iranian trademark infringers. What's behind this turn of events? |
The Motley Fool
June 14, 2005
Stephen D. Simpson |
Syneron Aims for Cellulite An FDA approval gives Israel's Syneron the lead in non-surgical cellulite treatment. With robust profit margins, that additional revenue could make a big impact on the bottom line. Investors, take note. |
InternetNews
May 31, 2005
Jim Wagner |
Latest Espionage Case Underlines Threat One of the biggest cases of industrial espionage in Israel throws a spotlight on the shadowy world of corporate competition and how easy it is to fall victim to a Trojan horse attached to e-mail. |
| <Older 61-70 Newer> Return to current articles. |
